...
vcyt-img

Veracyte Inc, Common Stock

VCYT

NASDAQ

$40.99

+$0.1

(0.24%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.17B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
705.29K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.67
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$18.61 L
$46 H
$40.99

About Veracyte Inc, Common Stock

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameVCYTSectorS&P500
1-Week Return-5.4%-0.94%-2.6%
1-Month Return-0.27%-5.08%-1.08%
3-Month Return19.64%-10.62%3.45%
6-Month Return78.68%-6.18%8.57%
1-Year Return43.62%1.98%24.3%
3-Year Return1.23%-0.93%25.58%
5-Year Return38.43%33.84%84.07%
10-Year Return401.71%102.52%185.12%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue120.37M117.48M219.51M296.54M361.05M[{"date":"2019-12-31","value":33.34,"profit":true},{"date":"2020-12-31","value":32.54,"profit":true},{"date":"2021-12-31","value":60.8,"profit":true},{"date":"2022-12-31","value":82.13,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue36.52M41.45M74.40M101.58M112.90M[{"date":"2019-12-31","value":32.35,"profit":true},{"date":"2020-12-31","value":36.72,"profit":true},{"date":"2021-12-31","value":65.9,"profit":true},{"date":"2022-12-31","value":89.97,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit83.84M76.03M145.11M194.95M248.15M[{"date":"2019-12-31","value":33.79,"profit":true},{"date":"2020-12-31","value":30.64,"profit":true},{"date":"2021-12-31","value":58.48,"profit":true},{"date":"2022-12-31","value":78.56,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin69.66%64.71%66.11%65.74%68.73%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":92.9,"profit":true},{"date":"2021-12-31","value":94.9,"profit":true},{"date":"2022-12-31","value":94.38,"profit":true},{"date":"2023-12-31","value":98.67,"profit":true}]
Operating Expenses98.97M111.42M227.02M236.03M333.94M[{"date":"2019-12-31","value":29.64,"profit":true},{"date":"2020-12-31","value":33.36,"profit":true},{"date":"2021-12-31","value":67.98,"profit":true},{"date":"2022-12-31","value":70.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(15.13M)(35.39M)(81.90M)(41.08M)(85.80M)[{"date":"2019-12-31","value":-1512700000,"profit":false},{"date":"2020-12-31","value":-3538900000,"profit":false},{"date":"2021-12-31","value":-8190300000,"profit":false},{"date":"2022-12-31","value":-4108100000,"profit":false},{"date":"2023-12-31","value":-8579500000,"profit":false}]
Total Non-Operating Income/Expense1.85M251.00K148.00K6.43M14.83M[{"date":"2019-12-31","value":12.48,"profit":true},{"date":"2020-12-31","value":1.69,"profit":true},{"date":"2021-12-31","value":1,"profit":true},{"date":"2022-12-31","value":43.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(12.60M)(34.91M)(81.65M)(36.43M)(76.61M)[{"date":"2019-12-31","value":-1259900000,"profit":false},{"date":"2020-12-31","value":-3490900000,"profit":false},{"date":"2021-12-31","value":-8164900000,"profit":false},{"date":"2022-12-31","value":-3642700000,"profit":false},{"date":"2023-12-31","value":-7661200000,"profit":false}]
Income Taxes3.88M938.00K(6.09M)133.00K(2.21M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":24.16,"profit":true},{"date":"2021-12-31","value":-156.77,"profit":false},{"date":"2022-12-31","value":3.43,"profit":true},{"date":"2023-12-31","value":-56.88,"profit":false}]
Income After Taxes(16.48M)(35.85M)(75.56M)(36.56M)(74.40M)[{"date":"2019-12-31","value":-1648100000,"profit":false},{"date":"2020-12-31","value":-3584700000,"profit":false},{"date":"2021-12-31","value":-7556300000,"profit":false},{"date":"2022-12-31","value":-3656000000,"profit":false},{"date":"2023-12-31","value":-7440400000,"profit":false}]
Income From Continuous Operations(12.60M)(34.91M)(75.56M)(36.56M)(49.95M)[{"date":"2019-12-31","value":-1259900000,"profit":false},{"date":"2020-12-31","value":-3490900000,"profit":false},{"date":"2021-12-31","value":-7556300000,"profit":false},{"date":"2022-12-31","value":-3656000000,"profit":false},{"date":"2023-12-31","value":-4995500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(16.48M)(35.85M)(75.56M)(36.56M)(74.40M)[{"date":"2019-12-31","value":-1648100000,"profit":false},{"date":"2020-12-31","value":-3584700000,"profit":false},{"date":"2021-12-31","value":-7556300000,"profit":false},{"date":"2022-12-31","value":-3656000000,"profit":false},{"date":"2023-12-31","value":-7440400000,"profit":false}]
EPS (Diluted)(0.27)(0.68)(0.59)(0.50)(1.03)[{"date":"2019-12-31","value":-27,"profit":false},{"date":"2020-12-31","value":-68,"profit":false},{"date":"2021-12-31","value":-59,"profit":false},{"date":"2022-12-31","value":-50,"profit":false},{"date":"2023-12-31","value":-103,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

VCYT
Cash Ratio 3.90
Current Ratio 5.08
Quick Ratio 4.79

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VCYT
ROA (LTM) 1.07%
ROE (LTM) -0.83%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VCYT
Debt Ratio Lower is generally better. Negative is bad. 0.08
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.92

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VCYT
Trailing PE NM
Forward PE 41.32
P/S (TTM) 7.45
P/B 2.57
Price/FCF 114
EV/R 6.52
EV/Ebitda 160.88
PEG NM

FAQs

What is Veracyte Inc share price today?

Veracyte Inc (VCYT) share price today is $40.99

Can Indians buy Veracyte Inc shares?

Yes, Indians can buy shares of Veracyte Inc (VCYT) on Vested. To buy Veracyte Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VCYT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Veracyte Inc be purchased?

Yes, you can purchase fractional shares of Veracyte Inc (VCYT) via the Vested app. You can start investing in Veracyte Inc (VCYT) with a minimum investment of $1.

How to invest in Veracyte Inc shares from India?

You can invest in shares of Veracyte Inc (VCYT) via Vested in three simple steps:

  • Click on Sign Up or Invest in VCYT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Veracyte Inc shares
What is Veracyte Inc 52-week high and low stock price?

The 52-week high price of Veracyte Inc (VCYT) is $46. The 52-week low price of Veracyte Inc (VCYT) is $18.61.

What is Veracyte Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Veracyte Inc (VCYT) is

What is Veracyte Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Veracyte Inc (VCYT) is 2.57

What is Veracyte Inc dividend yield?

The dividend yield of Veracyte Inc (VCYT) is 0.00%

What is the Market Cap of Veracyte Inc?

The market capitalization of Veracyte Inc (VCYT) is $3.17B

What is Veracyte Inc’s stock symbol?

The stock symbol (or ticker) of Veracyte Inc is VCYT

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top